Management of adult diabetic ketoacidosis from recent published articles
Reading File
Reading File
Reading File
Searching the Web
2024 2025 adult diabetic ketoacidosis consensus report management guidelines
Finding Sources
Finding Sources
Searching PubMed
"diabetic ketoacidosis"[MeSH Terms] AND management
Searching PubMed
"diabetic ketoacidosis"[MeSH Terms] AND insulin
Finding Sources
Reading Article
PMID: 39052901
Reading Article
PMID: 38154537
Reading Article
PMID: 41797565
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC11272983/
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC11272983/
Reading File
Searching PubMed
"diabetic ketoacidosis"[MeSH Terms] AND bicarbonate
Adult diabetic ketoacidosis: current management approach
This is a medical emergency requiring hospital-based care, frequent biochemical monitoring, and treatment of both the ketoacidosis and its precipitating cause. The main contemporary reference is the international ADA/EASD/JBDS/AACE/DTS 2024 consensus report, supported by newer reviews through 2026.
1. Confirm DKA and assess severity
The 2024 consensus diagnosis requires all three:
- Diabetes or hyperglycemia: glucose ≥200 mg/dL (11.1 mmol/L) or known diabetes
- Ketosis: blood beta-hydroxybutyrate ≥3.0 mmol/L or urine ketones ≥2+
- Metabolic acidosis: venous/arterial pH <7.30 and/or serum bicarbonate <18 mmol/L
Obtain immediately:
- Bedside glucose, vital signs, mental status, weight, volume status
- Venous blood gas, electrolytes including potassium, urea/creatinine, bicarbonate, magnesium and phosphate
- Serum beta-hydroxybutyrate, CBC, urinalysis, ECG
- Search for triggers: missed insulin or pump failure, infection, myocardial infarction, stroke, pancreatitis, trauma, alcohol/substance use, new diabetes, glucocorticoids/antipsychotics, and SGLT2 inhibitor use.
- In suspected euglycemic DKA, do not exclude DKA because glucose is below 250 mg/dL. This is especially relevant with SGLT2 inhibitors, pregnancy, fasting, or reduced carbohydrate intake.
The consensus report stratifies severe DKA by beta-hydroxybutyrate >6 mmol/L, pH <7.0 or bicarbonate <10 mmol/L, or altered consciousness. Severe DKA, shock, major comorbidity, or possible cerebral edema requires ICU-level care. The 2024 consensus report provides the current adult criteria.
2. Initial treatment priorities: fluids, potassium, insulin
A. IV fluid resuscitation
In adults without cardiac or renal compromise:
- Start 0.9% saline or a balanced crystalloid at 500-1,000 mL/hour for the first 2-4 hours.
- Then individualize fluid rate according to hemodynamics, urine output, sodium, fluid balance, and comorbidities.
- Aim to replace the deficit over 24-48 hours.
Balanced crystalloids such as Ringer lactate or Plasma-Lyte are reasonable first-line options and may reduce hyperchloremic acidosis and shorten time to DKA resolution compared with large-volume 0.9% saline. A 2024 systematic review found Plasma-Lyte non-inferior to saline and associated hyperchloremia with longer stay and slower resolution, although evidence quality and populations varied. Maharjan et al., 2024, PMID 38154537
Use smaller boluses, often 250 mL with reassessment, in older adults and patients with heart failure, advanced kidney disease, pregnancy, or other fluid-overload risk.
B. Potassium: assess before insulin
Although the presenting potassium may be normal or high, total-body potassium is depleted, usually by 3-6 mmol/kg. Insulin, correction of acidosis, and volume expansion all lower serum potassium.
| Serum potassium | Action |
|---|---|
| <3.5 mmol/L | Hold insulin. Give potassium, commonly 10 mmol/hour, until K is >3.5 mmol/L. Continuous ECG monitoring is appropriate in severe hypokalemia. |
| 3.5-5.0 mmol/L | Begin potassium replacement with fluids, usually 20-30 mmol/L, to target K 4-5 mmol/L. |
| >5.0 mmol/L | Do not initially add potassium, but check frequently and begin replacement once it falls below 5.0 mmol/L. |
Recheck potassium approximately 2 hours after starting insulin, then at least every 4 hours, more often if abnormal, renal function is impaired, or replacement is aggressive. Severe hypokalemia is associated with excess inpatient mortality. Consensus potassium recommendations
C. Insulin infusion
After fluids have begun and potassium is safe:
- Use regular insulin IV at 0.1 units/kg/hour as a fixed-rate infusion.
- An initial 0.1 units/kg IV bolus is not routinely necessary. It can be considered if obtaining IV access will delay starting the infusion.
- Aim for a glucose fall of about 50-75 mg/dL/hour.
When glucose reaches <250 mg/dL (13.9 mmol/L):
- Add dextrose 5%-10% to IV fluids.
- Reduce insulin to 0.05 units/kg/hour.
- Continue insulin until ketoacidosis resolves. Do not stop insulin merely because glucose is normal.
For uncomplicated mild or moderate DKA in alert, hemodynamically stable adults, rapid-acting subcutaneous insulin analog protocols every 1-2 hours can be used in an appropriately staffed observation or step-down setting. They are not preferred in severe DKA, shock, altered consciousness, or mixed DKA/HHS.
3. Glucose, electrolyte, and acid-base monitoring
During active treatment:
- Capillary glucose: every 1-2 hours
- Electrolytes, bicarbonate, creatinine, phosphate, and venous pH: every 4 hours, or more often if unstable
- Beta-hydroxybutyrate: serially where available
- Strict input/output, clinical fluid assessment, and cardiac monitoring when significant potassium disturbances exist.
Bicarbonate
Do not give bicarbonate routinely. Fluids and insulin correct ketoacidosis in most patients. Bicarbonate can worsen hypokalemia, reduce tissue oxygen delivery, and potentially cause paradoxical CNS acidosis.
Consider it only in extreme acidemia, generally pH <7.0. The 2024 consensus suggests 100 mmol sodium bicarbonate in 400 mL sterile water, repeated every 2 hours as necessary until pH exceeds 7.0, with close potassium monitoring.
A 2026 systematic review and meta-analysis of eight studies (646 participants) found no meaningful improvement in pH, time to acidosis resolution, or potassium outcomes with routine bicarbonate, and a possible longer hospital stay. It supports limiting bicarbonate to profound acidemia. Abu et al., 2026, PMID 41797565
Phosphate
Routine phosphate administration is not recommended. Consider replacement only if phosphate is <1.0 mmol/L with respiratory or cardiac compromise, hemolysis, or severe muscle weakness. If needed, potassium phosphate may be used while monitoring calcium, because rapid phosphate replacement can induce hypocalcemia.
4. Treat the precipitating cause
Insulin and fluids alone are insufficient if the driver is missed.
- Infection: examine clinically, obtain cultures/imaging only when indicated, and start empiric antibiotics if sepsis or a bacterial source is suspected.
- Acute coronary syndrome or stroke: ECG and targeted cardiac/neurologic assessment.
- Insulin omission or delivery failure: review access to insulin, injection technique, psychosocial barriers, insulin pump function, and sick-day education.
- SGLT2 inhibitor-associated DKA: stop the SGLT2 inhibitor during the episode. Recognize that glucose may be only mildly elevated. Continue insulin plus dextrose until ketonemia resolves, not until glucose alone normalizes.
- Pancreatitis, alcohol, starvation, or pregnancy: address specifically and involve relevant specialty teams early.
Harrison's notes that infection should be actively sought even without fever, and that SGLT2 inhibitor-associated DKA may present with normal or only mildly elevated glucose. Harrison’s Principles of Internal Medicine, 22nd ed., p. 3260.
5. Resolution and transition to subcutaneous insulin
DKA is resolved when:
- Plasma beta-hydroxybutyrate <0.6 mmol/L, and
- Venous pH ≥7.30 or bicarbonate ≥18 mmol/L.
Glucose should ideally also be <200 mg/dL, but glucose alone does not establish resolution. Avoid relying on the anion gap alone, because saline-related hyperchloremic acidosis may keep it elevated. Urine ketones are also unreliable during recovery because beta-hydroxybutyrate converts to acetoacetate. Resolution criteria
Transition principles
- Ensure the patient can eat or has an appropriate alternative insulin-dextrose plan.
- Give long-acting basal insulin before stopping IV insulin, with an overlap of at least 1-2 hours.
- For newly diagnosed adults, a total daily insulin dose is often initially estimated at 0.3-0.6 units/kg/day, adjusted for age, insulin sensitivity, renal impairment, nutritional intake, and hypoglycemia risk.
- Continuing or initiating basal insulin during the IV infusion can reduce rebound hyperglycemia and facilitate transition, provided the clinical team can monitor appropriately.
6. Prevention before discharge
Before discharge, address the reason for DKA and provide:
- Basal-bolus insulin plan and access to insulin/supplies
- Ketone testing instructions
- Sick-day rules: never stop basal insulin, maintain fluids and carbohydrate intake as feasible, increase monitoring, and seek early help for persistent ketones/vomiting
- Insulin pump troubleshooting if applicable
- SGLT2 inhibitor safety counseling
- Diabetes education and early outpatient endocrinology/diabetes follow-up
- Screening for cost barriers, mental health concerns, substance use, and social factors linked to recurrent DKA.
Evidence update
The major treatment algorithm remains the 2024 multinational consensus report: early isotonic or balanced crystalloid, potassium-guided insulin therapy, dextrose once glucose falls below 250 mg/dL, and avoidance of routine bicarbonate or phosphate. Recent systematic reviews do not materially overturn this approach. The newer evidence particularly supports careful avoidance of hypokalemia and selective use of balanced crystalloids rather than large volumes of saline.
Key references
- International adult hyperglycemic-crisis consensus report, 2024, Umpierrez et al. Diabetes Care. PMID: 39052901.
- Systematic review of emergency DKA interventions, 2024, Maharjan et al. Diabetes Research and Clinical Practice. PMID: 38154537.
- Bicarbonate systematic review and meta-analysis, 2026, Abu et al. Endocrinology, Diabetes & Metabolism. PMID: 41797565.
How to give pottasium supplements in diabetic ketoacidosis
Reading File
Finding Sources
Searching PubMed
"diabetic ketoacidosis"[MeSH Terms] AND potassium
Searching the Web
2024 consensus adult diabetic ketoacidosis potassium replacement <3.5 20 30 mmol per litre
Potassium replacement in adult DKA
Give potassium intravenously in hospital with repeat electrolytes and ECG monitoring when potassium is low. Do not rely on a normal or high initial potassium: total-body potassium is usually depleted, and insulin rapidly shifts potassium into cells.
Practical adult protocol
| Serum K+ | What to do |
|---|---|
| >5.0 mmol/L | Do not add potassium initially. Start fluids and insulin if otherwise appropriate. Recheck K+ in 2 hours. Start replacement once K+ falls below 5.0 mmol/L. |
| 3.5-5.0 mmol/L | Add 20-30 mmol potassium per litre of IV replacement fluid, commonly potassium chloride (KCl), aiming for K+ 4-5 mmol/L. Start insulin. |
| <3.5 mmol/L | Hold insulin. Give IV potassium at 10 mmol/hour until K+ is >3.5 mmol/L, then start or restart insulin and continue replacement. |
| ≤2.5 mmol/L, ECG changes, arrhythmia, or severe weakness | Urgent monitored/critical-care management. Hold insulin and replace potassium according to local high-risk IV potassium policy with continuous ECG monitoring. |
The current international consensus advises starting potassium replacement after K+ falls below 5.0 mmol/L, typically using 20-30 mmol/L in IV fluid; if K+ is <3.5 mmol/L, replace at 10 mmol/hour and defer insulin until K+ is >3.5 mmol/L. 2024 adult DKA consensus
How to administer it
- Preferred salt: usually potassium chloride (KCl) added to the prescribed crystalloid infusion.
- Potassium phosphate can substitute for some of the KCl if phosphate is also severely low or there is cardiac/respiratory muscle weakness. Do not give phosphate routinely.
- Never give IV potassium as a bolus or IV push.
- Follow local rules on maximum concentration and infusion rate for peripheral versus central lines. Higher concentrations/rates require a central line and cardiac monitoring.
- Assess urine output and renal function first. In anuric acute kidney injury or end-stage kidney disease, potassium replacement must be individualized and may be withheld.
Monitoring
- Measure K+ before insulin, then 2 hours after insulin begins, and at least every 4 hours until DKA resolves.
- Check glucose every 1-2 hours, and monitor bicarbonate, venous pH, creatinine, and ketones serially.
- If K+ falls below 3.5 mmol/L during treatment, stop insulin temporarily and give IV potassium.
- Continue insulin with dextrose once glucose falls below 250 mg/dL, because ketone clearance requires insulin, but only after potassium is safe.
Why this matters: DKA causes potassium loss from osmotic diuresis and vomiting, even when the initial serum K+ is high from acidosis and insulin deficiency. Insulin treatment, fluid resuscitation, and correction of acidosis can lower serum potassium by 1-2 mmol/L. Consensus potassium section
This protocol is for adults and should be performed by a clinical team, not self-administered.
This is a shared conversation. Sign in to Orris to start your own chat.